WATSON PHARMACEUTICALS INC
S-3, EX-23.4, 2001-01-05
PHARMACEUTICAL PREPARATIONS
Previous: WATSON PHARMACEUTICALS INC, S-3, EX-23.3, 2001-01-05
Next: WATSON PHARMACEUTICALS INC, S-3, EX-23.5, 2001-01-05



<PAGE>   1
                                                                    EXHIBIT 23.4


                         CONSENT OF INDEPENDENT AUDITORS

        We consent to the reference to our firm under the caption "Experts" and
to the use of and incorporation by reference of our report dated February 5,
1999, with respect to the consolidated financial statements of TheraTech, Inc.
for the years ended December 31, 1998 and 1997, included in Watson
Pharmaceuticals, Inc.'s Annual Report (Form 10-K) for the year ended December
31, 1999, and included and incorporated by reference in this Registration
Statement (Form S-3) and related prospectus of Watson Pharmaceuticals, Inc. for
the registration of 2,839,306 shares of its common stock.


/s/  ERNST & YOUNG LLP

Salt Lake City, Utah
January 3, 2001







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission